Abstract:To understand the dynamics of the cell cycle, we need to characterize the balance between cell cycle arrest and cell proliferation, which is often deregulated in cancers. We address this issue by means of a detailed computational model for the network of cyclin-dependent kinases (Cdks) driving the mammalian cell cycle. Previous analysis of the model focused on how this balance is controlled by growth factors (GFs) or the levels of activators (oncogenes) and inhibitors (tumour suppressors) of cell cycle progression. Supra-threshold changes in the level of any of these factors can trigger a switch in the dynamical behaviour of the Cdk network corresponding to a bifurcation between a stable steady state, associated with cell cycle arrest, and sustained oscillations of the various cyclin/Cdk complexes, corresponding to cell proliferation. Here, we focus on the regulation of cell proliferation by cellular environmental factors external to the Cdk network, such as the extracellular matrix (ECM), and contact inhibition, which increases with cell density. We extend the model for the Cdk network by including the phenomenological effect of both the ECM, which controls the activation of the focal adhesion kinase (FAK) that promotes cell cycle progression, and cell density, which inhibits cell proliferation via the Hippo/YAP pathway. The model shows that GFs and FAK activation are capable of triggering in a similar dynamical manner the transition to cell proliferation, while the Hippo/YAP pathway can arrest proliferation once cell density passes a critical threshold. The results account for the dependence or independence of cell proliferation on serum and/or cell anchorage to ECM. Whether the balance in the Cdk network is tilted towards cell cycle arrest or proliferation depends on the direction in which the threshold associated with the bifurcation is passed once the cell integrates the multiple, internal or external signals that promote or impede progression in the cell cycle.

Cyclins and cdks in development and cancer: a perspective

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Cell cycle, CDKs and cancer: a changing paradigm

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors

Cell cycle regulation and anticancer drug discovery

A review on the role of cyclin dependent kinases in cancers

The evolution of cyclin dependent kinase inhibitors in the treatment of cancer

The double dealing of cyclin D1

DNA Damage Checkpoint Recovery and Cancer Development

CYCLINS AND CELL CYCLE CHECKPOINTS

In my end is my beginning: control of end resection and DSBR pathway ‘choice’ by cyclin-dependent kinases

Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network

Development of Cell-Cycle Inhibitors for Cancer Therapy

Proliferation, cell cycle and apoptosis in cancer

Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma

CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents

Cell cycle control in cancer

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers

Progress in Clinical Trails of Cyclin Dependent Kinase Inhibitors

Cyclin E in normal physiology and disease states

The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition